{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T23:29:15Z","timestamp":1777591755314,"version":"3.51.4"},"reference-count":15,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2022,11,22]],"date-time":"2022-11-22T00:00:00Z","timestamp":1669075200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,11,22]],"date-time":"2022-11-22T00:00:00Z","timestamp":1669075200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch Dermatol Res"],"DOI":"10.1007\/s00403-022-02458-5","type":"journal-article","created":{"date-parts":[[2022,11,23]],"date-time":"2022-11-23T09:11:58Z","timestamp":1669194718000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Immunosuppressed patients are at increased risk of local recurrence, metastasis, and disease specific death from cutaneous squamous cell carcinoma"],"prefix":"10.1007","author":[{"given":"Adriana","family":"Lopez","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marianna","family":"Babadzhanov","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shayan","family":"Cheraghlou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Theresa","family":"Canavan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicole","family":"Doudican","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mary","family":"Stevenson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John A.","family":"Carucci","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,11,22]]},"reference":[{"issue":"11","key":"2458_CR1","doi-asserted-by":"publisher","first-page":"1192","DOI":"10.1001\/jamadermatol.2020.2571","volume":"156","author":"TM Lukowiak","year":"2020","unstructured":"Lukowiak TM et al (2020) Association of age, sex, race, and geographic region with variation of the ratio of basal cell to cutaneous squamous cell carcinomas in the United States. JAMA Dermatol 156(11):1192\u20131198","journal-title":"JAMA Dermatol"},{"issue":"8","key":"2458_CR2","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1016\/S1470-2045(08)70178-5","volume":"9","author":"KD Brantsch","year":"2008","unstructured":"Brantsch KD et al (2008) Analysis of risk factors determining prognosis of cutaneous squamous-cell carcinoma: a prospective study. Lancet Oncol 9(8):713\u2013720","journal-title":"Lancet Oncol"},{"issue":"11","key":"2458_CR3","doi-asserted-by":"publisher","first-page":"2054","DOI":"10.1002\/cncr.30601","volume":"123","author":"BV Manyam","year":"2017","unstructured":"Manyam BV et al (2017) A multi-institutional comparison of outcomes of immunosuppressed and immunocompetent patients treated with surgery and radiation therapy for cutaneous squamous cell carcinoma of the head and neck. Cancer 123(11):2054\u20132060","journal-title":"Cancer"},{"key":"2458_CR4","doi-asserted-by":"publisher","first-page":"2896","DOI":"10.3389\/fonc.2021.689789","volume":"11","author":"E Venanzi Rullo","year":"2021","unstructured":"Venanzi Rullo E et al (2021) Non-melanoma skin cancer in people living with HIV: from epidemiology to clinical management. Front Oncol 11:2896","journal-title":"Front Oncol"},{"issue":"3","key":"2458_CR5","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1016\/j.jaad.2021.01.063","volume":"85","author":"A Matsumoto","year":"2021","unstructured":"Matsumoto A et al (2021) Factors predicting outcomes of patients with high-risk squamous cell carcinoma treated with Mohs micrographic surgery. J Am Acad Dermatol 85(3):588\u2013595","journal-title":"J Am Acad Dermatol"},{"issue":"2","key":"2458_CR6","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1016\/j.jaad.2017.08.059","volume":"78","author":"SKT Que","year":"2018","unstructured":"Que SKT, Zwald FO, Schmults CD (2018) Cutaneous squamous cell carcinoma: Incidence, risk factors, diagnosis, and staging. J Am Acad Dermatol 78(2):237\u2013247","journal-title":"J Am Acad Dermatol"},{"issue":"1","key":"2458_CR7","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1016\/j.jaad.2018.06.060","volume":"80","author":"J Ca\u00f1ueto","year":"2019","unstructured":"Ca\u00f1ueto J et al (2019) Comparing the eighth and the seventh editions of the American joint committee on cancer staging system and the brigham and women\u2019s Hospital alternative staging system for cutaneous squamous cell carcinoma: Implications for clinical practice. J Am Acad Dermatol 80(1):106-113.e2","journal-title":"J Am Acad Dermatol"},{"issue":"5","key":"2458_CR8","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.1111\/j.1365-2133.2012.10830.x","volume":"166","author":"A Lomas","year":"2012","unstructured":"Lomas A, Leonardi-Bee J, Bath-Hextall F (2012) A systematic review of worldwide incidence of nonmelanoma skin cancer. Br J Dermatol 166(5):1069\u20131080","journal-title":"Br J Dermatol"},{"issue":"8","key":"2458_CR9","doi-asserted-by":"publisher","first-page":"932","DOI":"10.1097\/DSS.0000000000000798","volume":"42","author":"ML Stevenson","year":"2016","unstructured":"Stevenson ML et al (2016) Metastatic cutaneous squamous cell carcinoma: the importance of T2 stratification and hematologic malignancy in prognostication. Dermatol Surg 42(8):932\u2013935","journal-title":"Dermatol Surg"},{"issue":"7","key":"2458_CR10","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1001\/jamadermatol.2019.0032","volume":"155","author":"ES Ruiz","year":"2019","unstructured":"Ruiz ES et al (2019) Performance of the American joint committee on cancer staging manual, 8th edition vs the brigham and women\u2019s hospital tumor classification system for cutaneous squamous cell carcinoma. JAMA Dermatol 155(7):819\u2013825","journal-title":"JAMA Dermatol"},{"issue":"9","key":"2458_CR11","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.1097\/DSS.0000000000001774","volume":"45","author":"AB Blechman","year":"2019","unstructured":"Blechman AB, Carucci JA, Stevenson ML (2019) Stratification of poor outcomes for cutaneous squamous cell carcinoma in immunosuppressed patients using the American joint committee on cancer eighth edition and brigham and women\u2019s hospital staging systems. Dermatol Surg 45(9):1117\u20131124","journal-title":"Dermatol Surg"},{"issue":"8","key":"2458_CR12","first-page":"579","volume":"10","author":"H Breuninger","year":"2012","unstructured":"Breuninger H et al (2012) Comparison and evaluation of the current staging of cutaneous carcinomas. J Dtsch Dermatol Ges 10(8):579\u2013586","journal-title":"J Dtsch Dermatol Ges"},{"issue":"4","key":"2458_CR13","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1001\/jamadermatol.2017.6428","volume":"154","author":"I Roscher","year":"2018","unstructured":"Roscher I et al (2018) Validating 4 staging systems for cutaneous squamous cell carcinoma using population-based data: a nested case-control study. JAMA Dermatol 154(4):428\u2013434","journal-title":"JAMA Dermatol"},{"issue":"4","key":"2458_CR14","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1001\/jamadermatol.2015.4994","volume":"152","author":"AK Thompson","year":"2016","unstructured":"Thompson AK et al (2016) Risk factors for cutaneous squamous cell carcinoma recurrence, metastasis, and disease-specific death: a systematic review and meta-analysis. JAMA Dermatol 152(4):419\u2013428","journal-title":"JAMA Dermatol"},{"key":"2458_CR15","doi-asserted-by":"publisher","unstructured":"Caudill J, Thomas JE, Burkhart CG (2022) The risk of metastases from squamous cell carcinoma of the skin. Int J Dermatolc Open Access https:\/\/doi.org\/10.1111\/ijd.16164","DOI":"10.1111\/ijd.16164"}],"container-title":["Archives of Dermatological Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00403-022-02458-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00403-022-02458-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00403-022-02458-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,23]],"date-time":"2022-11-23T09:21:02Z","timestamp":1669195262000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00403-022-02458-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11,22]]},"references-count":15,"alternative-id":["2458"],"URL":"https:\/\/doi.org\/10.1007\/s00403-022-02458-5","relation":{},"ISSN":["1432-069X"],"issn-type":[{"value":"1432-069X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,11,22]]},"assertion":[{"value":"15 October 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 November 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 November 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Dr. Lopez has no disclosures. Marianna Babadzhanov has no disclosures. Dr. Canavan has no disclosures. Dr. Cheraghlou has no disclosures. Dr. Doudican has no disclosures. Dr. Stevenson has no disclosures. Dr. Carucci receives funding for investigator initiated basic science research from Regeneron\/Sanofi. The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Confict of interest"}}]}}